tricalcium phosphate has been researched along with lumefantrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janakiraman, K; Kandasamy, R; Krishnaswami, V; Natesan, S; Sethuraman, V | 2 |
2 other study(ies) available for tricalcium phosphate and lumefantrine
| Article | Year |
|---|---|
pH responsive delivery of lumefantrine with calcium phosphate nanoparticles loaded lipidic cubosomes for the site specific treatment of lung cancer.
Topics: A549 Cells; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Calcium Phosphates; Cell Membrane Permeability; Cell Survival; Drug Compounding; Drug Liberation; Excipients; Humans; Hydrogen-Ion Concentration; Lipids; Lumefantrine; Lung Neoplasms; Molecular Targeted Therapy; Nanocapsules; Rats, Inbred WF | 2019 |
In vivo synergistic anti-tumor effect of lumefantrine combined with pH responsive behavior of nano calcium phosphate based lipid nanoparticles on lung cancer.
Topics: Animals; Calcium Phosphates; Hydrogen-Ion Concentration; Lipids; Lumefantrine; Lung Neoplasms; Mice; Nanoparticles | 2021 |